The reasons for triple therapy in stable COPD patients in Japanese clinical practice

BACKGROUND: Triple combination therapy involving long-acting muscarinic antagonists long-acting β(2) agonists, and inhaled corticosteroids has recently become an option for maintenance treatment of COPD. Some add-on clinical trials have reported the benefits of these combinations. However, the proce...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Masaki, Nakamura, Hidetoshi, Takahashi, Saeko, Chubachi, Shotaro, Sasaki, Mamoru, Haraguchi, Mizuha, Terai, Hideki, Ishii, Makoto, Fukunaga, Koichi, Tasaka, Sadatomo, Soejima, Kenzo, Asano, Koichiro, Betsuyaku, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461139/
https://www.ncbi.nlm.nih.gov/pubmed/26082629
http://dx.doi.org/10.2147/COPD.S79864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461139/
https://www.ncbi.nlm.nih.gov/pubmed/26082629
http://dx.doi.org/10.2147/COPD.S79864

Ejemplares similares